Bladder Cancer最新文献

筛选
英文 中文
Selection, Administration and Description of Neoadjuvant versus Adjuvant Therapy for Upper Tract Urothelial Carcinoma 上尿路上皮癌新辅助治疗与辅助治疗的选择、给药和描述
IF 1.1 4区 医学
Bladder Cancer Pub Date : 2021-01-01 DOI: 10.1007/978-3-030-70646-3_39
R. Shotton, A. Birtle
{"title":"Selection, Administration and Description of Neoadjuvant versus Adjuvant Therapy for Upper Tract Urothelial Carcinoma","authors":"R. Shotton, A. Birtle","doi":"10.1007/978-3-030-70646-3_39","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_39","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"28 6: High Density Integr. Multipurpose Photon. Circ.","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50974396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Adjuvant Therapies for Upper Tract Urothelial Carcinoma After Endoscopic Management 内镜治疗后上尿路上皮癌的新辅助疗法
IF 1.1 4区 医学
Bladder Cancer Pub Date : 2021-01-01 DOI: 10.1007/978-3-030-70646-3_37
Pranav Sharma, P. Spiess
{"title":"Novel Adjuvant Therapies for Upper Tract Urothelial Carcinoma After Endoscopic Management","authors":"Pranav Sharma, P. Spiess","doi":"10.1007/978-3-030-70646-3_37","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_37","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"62 5","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50974345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radical Cystectomy 根治
IF 1.1 4区 医学
Bladder Cancer Pub Date : 2021-01-01 DOI: 10.1007/978-3-030-70646-3_14
S. Ghodoussipour, S. Daneshmand, F. Burkhard, B. Kiss, G. Thalmann, N. Aldhaam, A. Elsayed, A. Hussein, K. Guru, M. Moschini, M. Saad, X. Cathelineau, R. Sanchez-Salas, Utsav K Bansal, S. Lerner
{"title":"Radical Cystectomy","authors":"S. Ghodoussipour, S. Daneshmand, F. Burkhard, B. Kiss, G. Thalmann, N. Aldhaam, A. Elsayed, A. Hussein, K. Guru, M. Moschini, M. Saad, X. Cathelineau, R. Sanchez-Salas, Utsav K Bansal, S. Lerner","doi":"10.1007/978-3-030-70646-3_14","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_14","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"29 4: Biophotonics","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50973939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative Preparation and Management of Cystoscopy Patient 膀胱镜患者围手术期的准备与处理
IF 1.1 4区 医学
Bladder Cancer Pub Date : 2021-01-01 DOI: 10.1007/978-3-030-70646-3_6
F. Goravanchi
{"title":"Perioperative Preparation and Management of Cystoscopy Patient","authors":"F. Goravanchi","doi":"10.1007/978-3-030-70646-3_6","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_6","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"80 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50974491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer. 比较低危和中低危非肌浸润性膀胱癌患者监测方案的随机可行性试验。
IF 1.1 4区 医学
Bladder Cancer Pub Date : 2021-01-01 DOI: 10.3233/blc-201535
Ryan M Reyes, Emily Rios, Shane Barney, Cory M Hugen, Joel E Michalek, Yair Lotan, Edward M Messing, Robert S Svatek
{"title":"A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer.","authors":"Ryan M Reyes, Emily Rios, Shane Barney, Cory M Hugen, Joel E Michalek, Yair Lotan, Edward M Messing, Robert S Svatek","doi":"10.3233/blc-201535","DOIUrl":"10.3233/blc-201535","url":null,"abstract":"<p><strong>Background: </strong>Surveillance regimens for non-muscle invasive bladder cancer (NMIBC) are disparate and controlled trials could inform guidelines. The feasibility of randomizing patients to variable frequency surveillance is unknown.</p><p><strong>Objectives: </strong>To determine patient willingness to randomization to high frequency (HF) versus low frequency (LF) surveillance regimen for NMIBC and compare patient comfort and healthcare costs across regimens.</p><p><strong>Methods: </strong>A non-blinded, two-arm, randomized-controlled study of patients with low or low-intermediate risk NMIBC was conducted at two institutions where patients were offered randomization to HF vs. LF surveillance following initial tumor resection. The HF group underwent cystoscopy every three months for 2 years, then every 6 months for 2 years, then annually. The LF group underwent cystoscopy at 9 months following the 3-month cystoscopy, then annually. Assuming 75% of patients approached would agree to enrollment, a sample size of <i>n</i> = 35 patients per arm provided a one-sided 95% exact Clopper-Pearson confidence lower-limit of 60%.</p><p><strong>Results: </strong>Of 70 patients approached, 45 (64.3%) agreed to participate and 25 (35.7%) declined enrollment due to preference for HF. Twelve biopsies were performed, including 4 (19%) of 21 patients in the HF group and 8 (33.3%) of 24 patients in the LF group. Disease recurrence (low grade Ta) was observed in 3 (14.3%) and 5 (20.8%) patients in the HF and LF groups, respectively. No patients experienced high grade recurrence or progression. Both groups had similar patient-reported procedure-related discomfort and quality of life measures over time. Patient out-of-pocket cost and healthcare systems costs were $383.80 more per patient annually in the HF group.</p><p><strong>Conclusions: </strong>Randomization to variable frequency surveillance is challenging as over a third of patients declined participation. However, these data provide important preliminary insights into the potential effects of surveillance frequency on oncologic and economic outcomes in patients with low and low-intermediate risk bladder cancer.</p>","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"7 3","pages":"285-295"},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/blc-201535","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39498272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Bladder Cancer Screening, Signs and Symptoms, and Workup 膀胱癌筛查、体征、症状和检查
IF 1.1 4区 医学
Bladder Cancer Pub Date : 2021-01-01 DOI: 10.1007/978-3-030-70646-3_1
J. Meeks
{"title":"Bladder Cancer Screening, Signs and Symptoms, and Workup","authors":"J. Meeks","doi":"10.1007/978-3-030-70646-3_1","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_1","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"12 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50973566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continent Cutaneous Urinary Diversions 大陆皮肤尿改道
IF 1.1 4区 医学
Bladder Cancer Pub Date : 2021-01-01 DOI: 10.1007/978-3-030-70646-3_18
S. Basourakos, D. Scherr
{"title":"Continent Cutaneous Urinary Diversions","authors":"S. Basourakos, D. Scherr","doi":"10.1007/978-3-030-70646-3_18","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_18","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"57 10","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50974212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing Nutritional Status in Patients Undergoing Radical Cystectomy: A Systematic Scoping Review. 优化根治性膀胱切除术患者的营养状况:系统性范围审查。
IF 1 4区 医学
Bladder Cancer Pub Date : 2021-01-01 Epub Date: 2021-12-13 DOI: 10.3233/blc-200428
Syed M Alam, Carrie Michel, Hilary Robertson, Juliana T Camargo, Brenda Linares, Jeffrey Holzbeierlein, Jill Hamilton-Reeves
{"title":"Optimizing Nutritional Status in Patients Undergoing Radical Cystectomy: A Systematic Scoping Review.","authors":"Syed M Alam, Carrie Michel, Hilary Robertson, Juliana T Camargo, Brenda Linares, Jeffrey Holzbeierlein, Jill Hamilton-Reeves","doi":"10.3233/blc-200428","DOIUrl":"10.3233/blc-200428","url":null,"abstract":"<p><strong>Background: </strong>Nutrition is a modifiable risk factor for patients undergoing multimodal oncologic interventions and plays a major supportive role in the setting of bladder cancer. For patients undergoing radical cystectomy (RC), malnutrition is associated with increased postoperative complications and mortality.</p><p><strong>Objectives: </strong>The purpose of this scoping review is to characterize the role of nutritional interventions for patients undergoing RC for bladder cancer.</p><p><strong>Methods: </strong>A multi-database systematic scoping review based on the Preferred Reporting Items for Systematic Reviews extension for Scoping Reviews (PRISMA-ScR) guidelines was performed. Search terms were developed <i>a priori</i> to identify clinical trials that focused on nutritional interventions for patients with bladder cancer undergoing RC. Eligible articles were original research articles or abstracts from clinical trials evaluating nutritional interventions in adult patients undergoing RC. Articles were excluded if they did not focus on a nutritional intervention, if patients did not carry a diagnosis of bladder cancer, or if RC was not performed. Articles were reviewed independently by the authors, and inclusion/exclusion were based on consensus agreement.</p><p><strong>Results: </strong>A total of 83 articles were identified, of which 17 were included in the final analysis. A total of 49 articles were excluded during abstract screening. An additional 17 articles were excluded based on the review of full-text articles. Results of the scoping review suggest that data on the use of nutritional screening, assessment, and intervention for patients undergoing RC are scarce. Although parenteral nutrition (PN) appears to be associated with greater complications after RC, early introduction of food postoperatively or feeding enterally offers benefit and immunonutrition supplements with a focus on a high protein diet has the potential to better optimize surgical outcomes.</p><p><strong>Conclusions: </strong>Although the prevalence and consequences of malnutrition among patients undergoing RC are well-established, there are limited data evaluating the use of nutritional screening, assessment, and interventions for this population. The pursuit of future clinical trials in this space is critical.</p>","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"7 4","pages":"449-461"},"PeriodicalIF":1.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/66/a0/blc-7-blc200428.PMC8730471.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39791992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC) 非肌肉浸润性膀胱癌的肿瘤监测
IF 1.1 4区 医学
Bladder Cancer Pub Date : 2021-01-01 DOI: 10.1007/978-3-030-70646-3_13
Vishnukamal Golla, K. Chamie
{"title":"Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC)","authors":"Vishnukamal Golla, K. Chamie","doi":"10.1007/978-3-030-70646-3_13","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_13","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"54 6","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50973927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using Urinary Biomarkers in Urothelial Carcinoma of the Bladder and Upper Tracts 应用尿液生物标志物在膀胱和上尿路尿路上皮癌中的应用
IF 1.1 4区 医学
Bladder Cancer Pub Date : 2021-01-01 DOI: 10.1007/978-3-030-70646-3_3
R. Ghandour, N. Singla, Y. Lotan
{"title":"Using Urinary Biomarkers in Urothelial Carcinoma of the Bladder and Upper Tracts","authors":"R. Ghandour, N. Singla, Y. Lotan","doi":"10.1007/978-3-030-70646-3_3","DOIUrl":"https://doi.org/10.1007/978-3-030-70646-3_3","url":null,"abstract":"","PeriodicalId":54217,"journal":{"name":"Bladder Cancer","volume":"74 3","pages":""},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50974153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信